William Cance, deputy director of the University of Arizona Cancer Center in Phoenix, was appointed interim director of the UA Cancer Center, effective July 1.
Thomas Jefferson University and Temple University have agreed on a 90-day extension of the due diligence period for the purchase of Temple-owned Fox Chase Cancer Center.
Dany Habr has joined Pfizer Oncology as chief medical officer as of April 15.
Lisa Kachnic was named chair of the Department of Radiation Oncology at the Columbia University Vagelos College of Physicians and Surgeons and chief of the radiation oncology service at New York-Presbyterian/Columbia University Irving Medical Center effective Sept. 1. She will also serve as associate director for Cancer Network Strategy in the Herbert Irving Comprehensive Cancer Center.
The Conquer Cancer Foundation of the American Society of Clinical Oncology announced the recipients of its 2019 ASCO Annual Meeting Merit Awards. These awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO annual meeting.
International Myeloma Foundation co-founder and president, Susie Durie, and Chairman Brian Durie were awarded a joint honorary doctorate for scientific excellence from the Vrije Universiteit Brussel at a ceremony in Brussels.
Western Connecticut Health Network has announced the appointment of Margo Shoup as the new network chair of the cancer service line. Shoup will provide strategic and clinical leadership for all aspects of WCHN's cancer services, including medical oncology and subspecialty practices.
The NCI Board of Scientific Advisors approved eight new Requests for Applications, Requests for Proposals, and PAR—a program announcement reviewed in the institute—concepts at a meeting March 25, including three new Cancer Moonshot concepts.
We posed the same 10 questions to FDA, Pfizer and Flatiron Health. Here is what came back:
